Positive Development, a provider of developmental therapy for autistic children, has secured a $45 million debt facility from Silicon Valley Bank and Pinegrove Venture Partners. The non-dilutive financing refinances the company's existing credit facility and will support geographic expansion, strategic acquisitions and increased care access through commercial and Medicaid health plans. The facility follows Positive Development's recent $51.5 million Series C funding and expansion of partnerships with Anthem Blue Cross and Blue Shield and Oklahoma Complete Health. Founded in 2020, the company operates as the largest provider of developmental therapy in the United States, offering what it describes as a lower-intensity, lower-cost approach to autism care using developmental relationship-based interventions. The company aims to make its therapy model accessible to families nationwide across all payer types.

Leading provider of developmental therapy for autistic children and their families, Positive Development announces $51.5M in Series C funding.

Positive Development, based in McLean, Virginia, has secured $51.5 million in Series C funding. This investment supports the company's growth in developmental therapy for autistic children and their families. The funding will likely be used for market expansion, service development, and research. This reflects a broader trend of increased investment in specialized healthcare services, driven by rising demand for autism support.